Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs

Journal of Addiction Medicine

Volumn 8, Issue 1, 2014, Pages 59-65

  Muilenburg, Jessica L ^a   Laschober, Tanja C ^a   Eby, Lillian T ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Co occurring disorders; Pharmacotherapy; Smoking treatment; Substance abuse; Tobacco cessation

Indexed keywords

ARTICLE; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RANDOM SAMPLE; SKILL; SMOKING CESSATION; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; TOBACCO CESSATION PHARMACOTHERAPY; TOBACCO DEPENDENCE; UNITED STATES;

HEALTH PERSONNEL; HUMANS; REGRESSION ANALYSIS; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 84898759623     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000008     Document Type: Article

References (40)

1. Bollen KA. Multiple indicators: Internal consistency or no necessary relationship? Qual Quantity 1984;18:377-385.
2. Bollen KA, Lennox R. Conventional wisdom on measurement: A structural equation perspective. Psychol Bull 1991;110:305-314.
3. Breslau N, Peterson E, Schultz L, et al. Are smokers with alcohol disorders less likely to quit? Am J Public Health 1996;86:985-990.
4. Brigham GS, Schroeder G, Schindler E. Addressing smoking in community drug abuse treatment programs: Practical and policy considerations. J Psychoactive Drugs 2007;39:435-441.
5. Choi JN,Chang JY. Innovation implementation in the public sector: An integration of institutional and collective dynamics. J Appl Psychol 2009;94:245-253.
6. Clarke JG, Stein MD,McGarry KA, et al. Interest in smoking cessation among injection drug users. Am J Addict 2001;10:159-166.
7. Diamantopoulus A, Winklhofer HM. Index construction with formative indicators: An alternative to scale development. J Mark Res 2001;38:269-277.
8. Dong L, Neufeld DJ, Higgins C. Testing Klein and Sorra's innovation implementation model: An empirical examination. J Eng Technol Manage 2008;25:237-255.
9. Ellingstad TP, Sobell LC, Sobell MB, et al. Alcohol abusers who want to quit smoking: Implications for clinical treatment. Drug Alcohol Depend 1999;54:259-264.
10. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. 2008. Available at http://www.surgeongeneral.gov/ tobacco/treating tobacco use08.pdf. Accessed April 20, 2013.
11. Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat 2008;34:165-172.
12. Fuller BE, Guydish J, Tsoh J, et al. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat 2007;32:53-60.
13. Gripp SI, Luloff AE, Yonkers RD. Reporting response rates for telephone surveys used in agricultural economics research. Agric Res Econ Rev 1994;23:200-206.
14. Guydish J, Passalacqua E, Tajima B, et al. Smoking prevalence in addiction treatment: A review. Nicotine Tob Res 2011;13:401-411.
15. Guydish J, Passalacqua E, Tajima B, et al. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: A review. J Psychoactive Drugs 2007;39:423-433.
16. Hansen GR, Leshner AI, Tai B. Putting drug abuse research to use in real-life settings. J Subst Abuse Treat 2002;23:69-70.
17. Hays JT, Schroeder DR, Offord KP, et al. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med 1999;21:244-250.
18. Hunt JJ, Cupertino AP, Garrett S, et al. How is tobacco treatment provided during drug treatment? J Subst Abuse Treat 2012;42:4-15.
19. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA 1996;275:1097-1103.
20. Kalman D, Kim S, DiGirolamo G, et al. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev 2010;30:12-24.
21. Klein KJ, Sorra JS. The challenge of innovation implementation. Acad Manag Rev 1996;21:1055-1080.
22. Knudsen HK, Ducharme LJ, Roman PM, et al. Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. J Subst Abuse Treat 2005;29:95-106.
23. Knudsen HK, Studts JL. Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation. Drug Alcohol Depend 2011;118:244-250.
24. MacCallum RC, BrownMW. The use of causal modeling in covariance structure models: some practical issues. Psychol Bull 1993;114:533-551.
25. MacKenzie SB, Podsakoff PM, Jarvis CB. The problem of measurement modelmisspecification in behavioral and organizational research and some recommended solution. J Appl Psychol 2005;90:710-730
26. Mohaghegh Z, Kazemi R,Mosleh A. Incorporating organizational factors into Probabilistic Risk Assessment (PRA) of complex socio-technical systems: A hybrid technique formalization. Reliabil Eng Syst Saf 2009;94:1000-1018.
27. Morgenstern J, Blanchard KA, Morgan TJ, et al. Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings. JConsultClin Psychol 2011;69:1007-1017.
28. Nembhard IM, Alexander JA, Hoff TJ, et al. Why does the quality of health care continue to lag? Insights from management research. Acad Manage Perspect 2009;23:24-42.
29. Powell DJ, Brodsky A. Clinical Supervision in Alcohol and Drug Abuse Counseling: Principles,Models,Methods. San Francisco,CA: Jossey-Bass, 2004.
30. Ratschen E, Britton J, Doody GA, et al. Tobacco dependence, treatment and smoke-free policies: A survey of mental health professionals' knowledge and attitudes. Gen Hosp Psychiatry 2009;31:576-582.
31. Richter KP, Ahluwalia HK, Mosier MC, et al. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002;97:861-869.
32. Richter KP, Choi WS, McCool RM, et al. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatr Serv 2004;55:1258-1264.
33. Rieckmann TR, Kovas AE, McFarland BH, et al. A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment. J Subst Abuse Treat 2011;41:374-385.
34. Rohsendow DJ, Monti PM, Colby SM, et al. Naltrexone treatment for alcoholics: Effect on smoking cessation rates. Nicotine Tob Res 2003;5: 231-236.
35. Roman PM, Abraham AJ, Rothrauff TC, et al. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within theNationalDrugAbuse Treatment Clinical Trials Network. J Subst Abuse Treat 2010;38:S44-S52.
36. Rothrauff TC, Eby LT. Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. Am J Addict 2010;20:56-62.
37. Schoenwald SK, Sheidow AJ, Chapman JE. Clinical supervision in treatment transport: Effects on adherence and outcomes. J Consult Clin Psychol 2009;77:410-421.
38. U.S. Department of Health and Human Services. 2004. The health consequences of smoking: A report of the Surgeon General. Available at: Http://www.cdc.gov/tobacco/data statistics/sgr/2004/index.htm.
39. Weiner BJ, Lewis MA, Linnan LA. Using organization theory to understand the determinants of effective implementation of worksite health promotion programs. Health Educ Res 2009;24:292-305.
40. Ziedonis DM, Guydish J, Williams J, et al. Barriers and solutions to addressing tobacco dependence in addiction treatment. Alcohol Res Health 2006;29:228-235.